open access

Vol 27, No 5 (2020)
Editorial Comment
Submitted: 2020-06-12
Accepted: 2020-08-26
Published online: 2020-11-06
Get Citation

COVID-19 and its implication for venous thromboembolism

Michał Ciurzynski1, Justyna Domienik-Karłowicz1, Miłosz Jaguszewski2, Piotr Pruszczyk1
DOI: 10.5603/CJ.2020.0153
·
Pubmed: 33165897
·
Cardiol J 2020;27(5):481-484.
Affiliations
  1. Department of Internal Medicine and Cardiology with the Center for Diagnosis and Treatment of Thromboembolism, Medical University of Warsaw, Poland
  2. First Department of Cardiology, Medical University of Gdansk, Poland

open access

Vol 27, No 5 (2020)
Editorial comment — COVID-19
Submitted: 2020-06-12
Accepted: 2020-08-26
Published online: 2020-11-06

Abstract

Not available

Abstract

Not available
Get Citation
About this article
Title

COVID-19 and its implication for venous thromboembolism

Journal

Cardiology Journal

Issue

Vol 27, No 5 (2020)

Article type

Editorial Comment

Pages

481-484

Published online

2020-11-06

Page views

472

Article views/downloads

573

DOI

10.5603/CJ.2020.0153

Pubmed

33165897

Bibliographic record

Cardiol J 2020;27(5):481-484.

Authors

Michał Ciurzynski
Justyna Domienik-Karłowicz
Miłosz Jaguszewski
Piotr Pruszczyk

References (17)
  1. He J, Wu Bo, Chen Y, et al. Characteristic Electrocardiographic Manifestations in Patients With COVID-19. Can J Cardiol. 2020; 36(6): 966.e1–966.e4.
  2. Klok FA, Kruip M, van der Meer N, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thrombosis Res. 2020; 191: 145–147.
  3. Cui S, Chen S, Li X, et al. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(6): 1421–1424.
  4. Wichmann D, Sperhake JP, Lütgehetmann M, et al. Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study. Ann Intern Med. 2020; 173(4): 268–277.
  5. Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020; 46(6): 1089–1098.
  6. Marone EM, Bonalumi G, Curci R, et al. Characteristics of venous thromboembolism in COVID-19 patients: a multicenter experience from northern italy. Ann Vasc Surg. 2020 [Epub ahead of print].
  7. Tal S, Spectre G, Kornowski R, et al. Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far? Acta Haematol. 2020 [Epub ahead of print]: 1–8.
  8. Guo J, Huang Z, Lin Li, et al. Coronavirus disease 2019 (COVID-19) and cardiovascular disease: a viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection. J Am Heart Assoc. 2020; 9(7): e016219.
  9. Zhang Y, Xiao M, Zhang S, et al. Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19. N Engl J Med. 2020; 382(17): e38.
  10. Guan WJ, Ni ZY, Hu Yu, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382(18): 1708–1720.
  11. Tang N, Li D, Wang X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4): 844–847.
  12. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J. 2019; 54(3).
  13. Figliozzi S, Masci PG, Ahmadi N, et al. Predictors of adverse prognosis in COVID-19: A systematic review and meta-analysis. Eur J Clin Invest. 2020 [Epub ahead of print]: e13362.
  14. Kosior DA, Undas A, Kopeć G, et al. Guidance for anticoagulation management in venous thromboembolism during the coronavirus disease 2019 pandemic in Poland: an expert opinion of the Section on Pulmonary Circulation of the Polish Cardiac Society. Kardiol Pol. 2020; 78(6): 642–646.
  15. Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020; 75(23): 2950–2973.
  16. Thachil J, Tang N, Gando S, et al. ISTH interim guidance on recognition and management of coagulopathy in COVID-19. J Thromb Haemost. 2020; 18(5): 1023–1026.
  17. Moores LK, Tritschler T, Brosnahan S, et al. Prevention, diagnosis, and treatment of VTE in patients with coronavirus disease 2019: CHEST guideline and expert panel report. Chest. 2020; 158(3): 1143–1163.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl